Madrigal Pharmaceuticals(MDGL) - 2024 Q4 - Annual Results
Madrigal Pharmaceuticals(MDGL)2025-01-13 11:50(Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2025 MADRIGAL PHARMACEUTICALS, INC. Delaware 001-33277 04-3508648 (State or other jurisdiction of incorporation) Four Tower Bridge 200 Barr Harbor Drive, Suite 200 West Conshohocken, Pennsylvania 19428 (Address of principal exec ...